Written by: Sean Brady Edited by: Esther Melamed Who is commonly impacted and what are the common symptoms? It has been reported that between 36.4 – 82.3% of hospitalized Covid-19 patients present with neurological manifestations [1] (e.g., headache, brain fog, loss of smell, etc.). As the pandemic continues into 2021, It is becoming increasingly clear that many patients go on to have long-term neurological symptoms post initial COVID infection. This long-lasting condition has been called by many names, including “post-COVID syndrome”, “Long-COVID”, and most recently Post-Acute …
Blood oxygen level-dependent activation of the orbitofrontal cortex in COVID-19
Written by: Parker Davis Edited by: Esther Melamed Anosmia and ageusia – a loss of the sense of smell and taste, respectively – are well-documented symptoms of infection by SARS-CoV-2, the agent of COVID-19 (Vaira et al., 2020; Mak et al., 2020; Tanasa et al., 2020). Though the origins of these symptoms were initially somewhat mysterious, several hypotheses for their pathogenesis have been put forth: it is known, for example, that angiotensin-converting enzyme 2 – the putative receptor for SARS-CoV-2 – is found in large quantities in mucosal linings of the mouth and tongue, as well as in …
Acute brain dysfunction in COVID-19 intensive care patients can be mitigated with care and contact
Written by: Blaine Caslin Edited by: Esther Melamed While the vaccine rollout is bringing a glimmer of hope for the pandemic, many people are still getting hospitalized for COVID-19 and needing to be treated in the intensive care unit (ICU). Doctors and scientists are continuing to develop new clinical guidelines and models of care to save the lives of COVID-19 patients and to reduce the prevalence of chronic health problems in survivors. A recent study published in The Lancet Respiratory Medicine examined acute brain dysfunction in severely affected COVID-19 patients in the ICU in …